共 50 条
THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
被引:0
|作者:
Wielage, R. C.
[1
]
Muehlenbein, C. E.
[2
]
Liepa, A. M.
[2
]
Babineaux, S. M.
[2
]
Klein, R. W.
[1
]
Schwartzberg, L. S.
[3
]
机构:
[1] Med Decis Modeling Inc, Indianapolis, IN USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] West Clin, Memphis, TN USA
关键词:
D O I:
10.1016/S1098-3015(10)73257-5
中图分类号:
F [经济];
学科分类号:
02 ;
摘要:
引用
收藏
页码:A39 / A39
页数:1
相关论文